Although pharmaceutical marketing can lead to poor-quality prescribing and medicine use, less than half of all countries have a legislative framework in place to regulate it. Most countries instead rely on the pharmaceutical industry to regulate its own marketing practices using voluntary codes and guidelines.
Health Action International offers countries an innovative methodology to help determine the extent and impact of their pharmaceutical marketing regulation. Using research, interviews and data collection, the methodology can be easily carried out. The end result is a complete profile of national legislation, including its strengths, weaknesses and an analysis of stakeholder positions.